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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S134matrix metalloproteinase (MMP)-13 in cartilage explant culture. Although
the intracellular signaling that leads to cartilage destruction is mediated by
a cluster of catabolic pathways including mitogen-activated protein
kinases (MAPKs), the effect of CB12-II on MAPK pathways remains unclear.
Hyaluronan (HA) of high molecular weight is widely used in the treatment
of osteoarthritis (OA) by intra-articular injection. An increasing body of
evidence indicates that HA suppresses catabolic actions by proin-
ﬂammatory cytokine like interleukin-1. However, little is known of HA
effect on actions of CB12-II through interaction with HA receptor such as
intercellular adhesion molecule-1 (ICAM-1).
Purpose: This study was aimed to examine activation of p38 MAPK in
associationwith MMP-13 production by CB12-II and its inhibition by HA in
chondrocytes.
Methods: Cartilage explants harvested from OA knee joints or isolated
chondrocytes in monolayer were incubated with CB12-II or its scramble
peptide with or without pretreatment with 2700 kDa HA. In another set of
experiments, following preincubation with anti-ICAM-1 antibody or non-
speciﬁc IgG, cartilage explants were incubated with or without HA, fol-
lowed by coincubation with CB12-II or the scramble peptide.
Enzyme-linked immunosorbent assay for phosphorylated p38 and MMP-
13 was performed using total cell lysates and culture supernatants,
respectively.
Results: When cartilage explants or chondrocytes in monolayer were
incubated with CB12-II, the peptide activated p38 in association with
enhanced MMP-13 production. Inhibition studies with the speciﬁc inhib-
itor (SB203580) indicated the requirement of p38 for CB12-II-induced
MMP-13 production. Pretreatment with HA resulted in signiﬁcant
suppression of CB12-II-stimulated MMP-13 production in cartilage as well
as in chondrocyte monolayer cultures. HA suppressed p38 activation by
CB12-II, leading to a decrease in MMP-13 production. Anti-ICAM-1 anti-
body reversed HA effect on CB12-II action.
Conclusions: The present study clearly demonstrated that HA suppressed
CB12-II-activated p38 via ICAM-1 in OA articular chondrocytes. HA could
down-regulate the catabolic action of type II collagen fragments in oste-
oarthritic joints through the mechanism demonstrated in this study.
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IDENTIFICATION OF NEW ALTERNATIVE PATHWAYS AND THERAPEUTIC
TARGETS IN TNF-a-MEDIATED INFLAMMATION AND OSTEOLYSIS
INDUCED BY ULTRA-HIGH MOLECULAR WEIGHT POLYETHYLENE
Z. He 1, D.J. Leong 1, R.J. Majeska 2, J.A. Hardin 1, N.J. Cobelli 1,
H.B. Sun 1. 1Albert Einstein Coll. of Med., Bronx, NY; 2 The City Coll. of New
York, New York, NY, USA
Purpose: Osteolysis is the most common cause of failure for joint
replacement surgeries. Wear debris of prosthetic implants provoke
inﬂammatory responses, leading to osteoclast differentiation, osteolysis
and ultimately, implant loosening. Debris from implants, including ultra-
high molecular weight polyethylene (UHMWPE), one of the most common
materials used in arthroplasty, induce a variety of inﬂammatory responses,
including increased secretion of pro-inﬂammatory cytokine TNF-a (Tumor
necrosis factor alpha). A large body of literature has established the critical
role of TNF-a in UHMWPE-induced inﬂammation and osteolysis,
predominantly mediated via the RANKL/NF-kB pathway. However,
extensive efforts to prevent and treat prosthetic wear-induced osteolysis
by interfering with the TNF-a-associated RANKL/NF-kB pathway has seen
limited success. This suggests the existence of alternative pathways for
TNF-a-mediated inﬂammation and osteolysis. Accordingly, in the current
studies, we explored alternative molecular pathways by which TNF-a
might mediate inﬂammation and osteolysis induced by UHMWPE.
Methods: Osteoclast differentiation induction, UHMWPE treatment and
TNF-a inhibition: Bone marrow was harvested from TNF-a knockout and
wild-type C57/BL6 mice (Jackson Laboratories) according to our IACUC-
approved protocol and cultured. Marrow cells were induced for osteoclast
differentiation by M-CSF and RANKL. After 2 days of differentiation
induction, the cells were treated with UHMWPE particles (53-75mm,
Sigma) alone or with TNF-a inhibitor Inﬂiximab (Centocor Biotech). For
some experiments, cultures were treated with NF-kB inhibitor for 72 hrs
(Santa Cruz). Cellular and molecular assays: The cells were harvested for
qPCR and Western blot to measure targeted gene expression, or subject toTRAP staining (kit from Clontech) to determine osteoclast differentiation.
Cells without UHMWPE treatment were used as controls.
Results: Exposure to UHMWPE promotes differentiation of wild-type
marrow cells to osteoclasts (increased number of TRAP-positive osteoclast-
like cells), increases expression of TNF-a, TNF-a receptor 1 (TNF-aR1), and
multiple TNF targets including Snail1 and survivin in these cells, over
control (non-UHMWPE-treated) cultures. UHMWPE exposure fails to
enhance osteoclast differentiation, or increase expression of TNF receptor
or its downstream targets in TNF-a knockout cells, conﬁrming the critical
mediating role of TNF-a in UHMWPE-induced inﬂammation and osteol-
ysis. Interestingly, TNF inhibitor-a Inﬂiximab suppresses the osteoclast
differentiation and the upregulated expression of factors induced by
UHMWPE treatment in wild type cell culture; however, the UHMWPE
upregulated expression of Snail1 and survivin appeared not affected by
NF-kB inhibition.
Conclusions: Our results, in addition to substantiating the critical role of
TNF-a in UHMWPE-induced inﬂammation and osteolysis, identiﬁed
several downstream targets of TNF-a that are activated in response to
UHMWPE but are beyond the NF-kB pathway typically implicated in
osteoclastogenesis. These TNF-a targets have been shown to serve
important and relevant functions. Snail1 is critical for inﬂammatory-
induced cell migration, and survivin is an apoptosis inhibitor. Our results,
although preliminary, provide evidence of alternative pathway/factors in
addition to NF-kB through which TNF-a mediates UHMWPE-induced
inﬂammation and osteolysis. Our results are supported by recent reports of
TNF-a’s involvement in regulation of some signaling molecules, whose
expressions are not directly regulated by NF-kB. Further elucidation of
these alternative pathways will faciliate our understanding of the osteo-
lytic process induced by UHMWPE. The identiﬁcation of new TNF-a targets
may also promote prevention and treatment of osteolysis and the conse-
quent implant loosening induced by UHMWPE.
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THE EFFECT OF HIGH MOLECULAR HYALURONIC ACID ON THE
INDUCTION OF MATRIX DEGRADATION ENZYMES BY IL-6, IL-1b AND
TNF-a
M. Mihara, M. Hashizume. Chugai Pharmaceutical Co., Ltd, Gotemba, Japan
Purpose: Inﬂammatory cytokines, such as IL-6, IL-1b and TNF-a play role
of cartilage degeneration in rheumatoid arthritis and osteoarthritis. Intra-
articular injection of hyaluronate is now widely used in the treatment of
osteoarthritis. The main mechanism of HA for the prevention of cartilage
destruction and disease progression is thought to be an action in main-
taining the viscoelastic properties of synovial ﬂuid. In addition to this, we
and others have reported that HA down-regulated the expressions of
cartilage matrix degrading enzymes. In this study, we investigate the
inhibitory mechanism of high molecular weight hyaluronic acid (HA) on
the production of matrix metallopoteinases-3 (MMP-3) and a disintegrin
and metalloproteinase with thrombospondin motifs-4 (ADAMTS-4)
induced by IL-6, IL-1b and TNF-a in human articular chondrocytes.
Methods: Human articular chondrocytes were cultured with IL-6+soluble
IL-6 receptor (sIL-6R), IL-1b or TNF-a in the presence or absence of HA or
extracellular signal-regulated kinase (ERK) inhibitor for 24 h. Moreover,
chondrocyteswere culturedwith cytokineandHA in thepresenceorabsence
of mitogen-activated protein kinase phosphatase (MKP-1) inhibitor for 24 h.
After culture, MMP-3 and ADAMTS-4 mRNA expressions were measured by
